[ad_1]
The US Department of Justice has decided to put an end to a very close lawsuit by whistleblowers accusing Gilead Sciences Inc. of secretly organizing the manufacture of essential ingredients for taking HIV drugs in a Chinese facility with problems quality control.
Thursday's petition to a federal court in San Francisco came after the US Supreme Court dismissed Gilead's request in January to review a decision by the US Circuit's 9th Circuit Court of Appeal to reopen the lawsuit filed by two former employees. of Gilead under the False Claims Act.
To read the full article on WestlawNext Practitioner Insights, click here: bit.ly/2CKqtf0
Our standards:The principles of Thomson Reuters Trust.
Source link
